AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM
Clinical trial NCT05100641 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05100641
- Sponsor
- Aivita Biomedical, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2028-03-01
- Enrollment
- 672
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.